Catalyst Clinical Research - Company Market Research Report

Company Overview

• Name: Catalyst Clinical Research

• Mission: To inspire people to design and deliver better clinical trials.

• Founded: No information is available.

• Founders: No information is available.

• Key People and Roles:

• Chairman of the Board: Nick Dyer

• President & CEO: Nik Morton

• Senior VP, Strategy & Solutions: Melissa Church

• VP, People & Culture: Allison Crumpler, PCC

• CMO, Senior VP, Medical & Safety: Lisa Hornick, MD

• CIO: Deb Jones-Hertzog

• CCO: Kristin Judge

• VP, Clinical Development Operations: Svetlana Kolchinsky

• Senior VP, Catalyst Flex: Craig McIlloney

• CFO: Patti McNamara

• VP, Business Development: Sarah St. John, PhD

• Senior VP, Catalyst Oncology: Keya Watkins, PMP

• VP, Oncology Drug Development: Andrew Zupnick, PhD

• Headquarters: Wilmington, North Carolina, USA

• Number of Employees: 1,000+ staff across the globe in 25+ countries

• Revenue: No information is available.

• Core Competency: Known for full-service oncology clinical research, supporting innovative biopharmaceutical and biotechnology companies.

Products and Services

• Catalyst Flex:

• Specializes in providing flexible and scalable functional service provider (FSP) solutions.

• Key areas: Clinical operations, data management, biostatistics, programming, safety, and medical writing.

• Catalyst Oncology:

• Offers full-service oncology services for cancer clinical research.

• Supports drug development across a range of solid and hematologic indications, with a focus on innovative therapies.

• Key Features:

• Multithermatic functional service solutions.

• Specialized expertise in oncology clinical development.

• Collaboration with biotech companies for clinical trials.

• Global operations supporting studies in a wide array of cancer treatments.

Recent Developments

• New Developments: Catalyst Clinical Research has recently undertaken several initiatives to enhance its service offerings, including partnerships and participation in global oncology trials.

• Case Study - International Acute Myeloid Leukemia Study: Successfully managed a promising cancer therapy trial for acute myeloid leukemia (AML), moving into Phase II/III after a successful start and overcoming recruitment challenges.

• Focused Monitoring Support for Rare Disease Study: Catalyst Flex successfully helped a small biotech reverse trial declines and saved them approximately $1 million.

• Radiopharmaceutical Therapies: Emphasized innovation in radiopharmaceuticals as part of ongoing efforts to enhance cancer treatment options with smaller, targeted therapies.

• Company Culture and FSP Partnerships: Catalyst employs a robust company culture as a cornerstone of its collaboration model with partners, ensuring a sustainable, successful clinical trial delivery through FSP models.

• Strategic Partnerships:

• Partnered with technology and service companies like Medidata, Crucial Data Solutions, and Veeva Vault Safety to provide integrated solutions in clinical trials.

• Industry Engagement: Participated in key industry conferences such as SCOPE 2025, exploring themes like centralized trials and the impact of AI on outsourcing strategies.

Conclusion

Catalyst Clinical Research remains at the forefront of oncology clinical research, leveraging innovative practices, strategic partnerships, and a focused patient-centric approach. Their culture-driven model ensures high employee retention and quality delivery in the service of their biopharmaceutical clients. While financial metrics remain undisclosed, their global reach and extensive experience underscore their instrumental role in advancing cancer research therapies.